These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10427137)

  • 1. Modification of ceramide metabolism increases cancer cell sensitivity to cytotoxics.
    Lucci A; Han TY; Liu YY; Giuliano AE; Cabot MC
    Int J Oncol; 1999 Sep; 15(3):541-6. PubMed ID: 10427137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceramide toxicity and metabolism differ in wild-type and multidrug-resistant cancer cells.
    Lucci A; Giuliano AE; Han TY; Dinur T; Liu YY; Senchenkov A; Cabot MC
    Int J Oncol; 1999 Sep; 15(3):535-40. PubMed ID: 10427136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidrug resistance modulators and doxorubicin synergize to elevate ceramide levels and elicit apoptosis in drug-resistant cancer cells.
    Lucci A; Han TY; Liu YY; Giuliano AE; Cabot MC
    Cancer; 1999 Jul; 86(2):300-11. PubMed ID: 10421266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uncoupling ceramide glycosylation by transfection of glucosylceramide synthase antisense reverses adriamycin resistance.
    Liu YY; Han TY; Giuliano AE; Hansen N; Cabot MC
    J Biol Chem; 2000 Mar; 275(10):7138-43. PubMed ID: 10702281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agents that reverse multidrug resistance, tamoxifen, verapamil, and cyclosporin A, block glycosphingolipid metabolism by inhibiting ceramide glycosylation in human cancer cells.
    Lavie Y; Cao Ht; Volner A; Lucci A; Han TY; Geffen V; Giuliano AE; Cabot MC
    J Biol Chem; 1997 Jan; 272(3):1682-7. PubMed ID: 8999846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceramide glycosylation potentiates cellular multidrug resistance.
    Liu YY; Han TY; Giuliano AE; Cabot MC
    FASEB J; 2001 Mar; 15(3):719-30. PubMed ID: 11259390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulatory effect of tamoxifen and ICI 182,780 on adriamycin resistance in MCF-7 human breast-cancer cells.
    De Vincenzo R; Scambia G; Benedetti Panici P; Fattorossi A; Bonanno G; Ferlini C; Isola G; Pernisco S; Mancuso S
    Int J Cancer; 1996 Nov; 68(3):340-8. PubMed ID: 8903476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of glucosylceramide synthase, converting ceramide to glucosylceramide, confers adriamycin resistance in human breast cancer cells.
    Liu YY; Han TY; Giuliano AE; Cabot MC
    J Biol Chem; 1999 Jan; 274(2):1140-6. PubMed ID: 9873062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucosylceramide synthase blockade down-regulates P-glycoprotein and resensitizes multidrug-resistant breast cancer cells to anticancer drugs.
    Gouazé V; Liu YY; Prickett CS; Yu JY; Giuliano AE; Cabot MC
    Cancer Res; 2005 May; 65(9):3861-7. PubMed ID: 15867385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lactoferricin-induced apoptosis in estrogen-nonresponsive MDA-MB-435 breast cancer cells is enhanced by C6 ceramide or tamoxifen.
    Furlong SJ; Mader JS; Hoskin DW
    Oncol Rep; 2006 May; 15(5):1385-90. PubMed ID: 16596215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential oxygen radical susceptibility of adriamycin-sensitive and -resistant MCF-7 human breast tumor cells.
    Mimnaugh EG; Dusre L; Atwell J; Myers CE
    Cancer Res; 1989 Jan; 49(1):8-15. PubMed ID: 2535695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multidrug-resistant MCF-7 human breast cancer cell line which exhibits cross-resistance to antiestrogens and hormone-independent tumor growth in vivo.
    Vickers PJ; Dickson RB; Shoemaker R; Cowan KH
    Mol Endocrinol; 1988 Oct; 2(10):886-92. PubMed ID: 3185565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SDZ PSC 833 the drug resistance modulator activates cellular ceramide formation by a pathway independent of P-glycoprotein.
    Goulding CW; Giuliano AE; Cabot MC
    Cancer Lett; 2000 Feb; 149(1-2):143-51. PubMed ID: 10737718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing intracellular ceramide: an approach that enhances the cytotoxic response in prostate cancer cells.
    Wang H; Charles AG; Frankel AJ; Cabot MC
    Urology; 2003 May; 61(5):1047-52. PubMed ID: 12736045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale for sequential tamoxifen and anticancer drugs in adjuvant setting for patients with node- and receptor-positive breast cancer.
    Kim R; Tanabe K; Emi M; Uchida Y; Osaki A; Toge T
    Int J Oncol; 2005 Apr; 26(4):1025-31. PubMed ID: 15753998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of short-chain ceramide by human cancer cells--implications for therapeutic approaches.
    Chapman JV; Gouazé-Andersson V; Messner MC; Flowers M; Karimi R; Kester M; Barth BM; Liu X; Liu YY; Giuliano AE; Cabot MC
    Biochem Pharmacol; 2010 Aug; 80(3):308-15. PubMed ID: 20385104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycosylation of ceramide potentiates cellular resistance to tumor necrosis factor-alpha-induced apoptosis.
    Liu YY; Han TY; Giuliano AE; Ichikawa S; Hirabayashi Y; Cabot MC
    Exp Cell Res; 1999 Nov; 252(2):464-70. PubMed ID: 10527636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ceramide--antiestrogen nanoliposomal combinations--novel impact of hormonal therapy in hormone-insensitive breast cancer.
    Morad SA; Levin JC; Shanmugavelandy SS; Kester M; Fabrias G; Bedia C; Cabot MC
    Mol Cancer Ther; 2012 Nov; 11(11):2352-61. PubMed ID: 22962326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SDZ PSC 833, the cyclosporine A analogue and multidrug resistance modulator, activates ceramide synthesis and increases vinblastine sensitivity in drug-sensitive and drug-resistant cancer cells.
    Cabot MC; Giuliano AE; Han TY; Liu YY
    Cancer Res; 1999 Feb; 59(4):880-5. PubMed ID: 10029079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. beta-Sitosterol enhances tamoxifen effectiveness on breast cancer cells by affecting ceramide metabolism.
    Awad AB; Barta SL; Fink CS; Bradford PG
    Mol Nutr Food Res; 2008 Apr; 52(4):419-26. PubMed ID: 18338406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.